State and federal health officials are investigating a possible case of fungal meningitis receiving steroids accused of shooting Framingham pharmacy compounding center in New England, Massachusetts, a woman, troubled fungal meningitis outbreak.
The 71-year-old Andover woman shooting back pain, August, September, and October 1, Lawrence, Merrimack Valley Pain Management Association, said her lawyer, Peter McGrath, Concord, New Hampshire
"October 23, she became very hard, was rushed to hospital for treatment of headaches, body aches, fever and all the classic sytmptoms, meningitis," McGrath said.
He said he saw her discharge papers Lawrence General Hospital, the diagnosis of fungal meningitis.
The three contaminated steroids alongside countries outbreak - acetic acid methyl - not be shipped to Massachusetts, health care providers, according to federal health officials. Each Win New England compounding drugs listed by the U.S. Food and Drug Administration (FDA) on May 21, because the Merrimack Valley Pain Management received two batches of the same type of steroid in June and July. 50 dose for each shipment.
Arrive Friday night, Dr. Lamy Rustum, medical director of the Merrimack Valley, pain management, patients receiving compound interest from the New England acetate, methyl prednisolone for three injections, she had been hospitalized. But he said his clinic has health problems from other patients injected missed calls. He said, told him Friday, said the hospital has not treated patients with fungal meningitis, but he said he did not ask the Andover woman at Lawrence General Hospital infectious disease specialist.
Lawrence said, can not comment.
Mixing links with the federal Centers for Disease Control and Prevention (CDC), the New England steroid injection of 480 fungal diseases, mostly meningitis, and death of 33 people in 19 states.
Massachusetts health officials on Friday night issued a statement saying: "We are working in collaboration with the Centers for Disease Control and Prevention, this case, which is not recognized in the case of fungal meningitis at this time, their investigation as part of We have also been in close contact with the patients treated in the hospital. although Massachusetts did not receive any contamination of a large number of the NECC, we will take all possible serious ... we hope in her rehabilitation patients.
Fungal meningitis is extremely rare, and the woman's case, if confirmed, this will increase the possibility of contamination of the other batch methylprednisolone acetate.
Last month, federal health officials said they are investigating fungal infections in patients who received other products from the New England compounding. A patient may be meningitis after receiving another steroid injection, another patient has cardioplegia in cardiac surgery. Officials did not confirm the compounding diseases in these patients from New England.
Reached by telephone Friday night, Andover woman, who asked Earth does not recognize her, speak impatiently end the conversation quickly. She said she did not know specifically what steroid to her doctor diagnosed her with the end of October a form of meningitis.
The woman explained that she did not feel the "standard" told reporters, "This is bad, because it is, I just do not want to continue" the conversation.
No comments:
Post a Comment